FindTrial
Sign In

MR lymphangiographic and Lymphoscintigraphic Bilateral Disease in Patients with Clinically Unilateral Cancer-related Lower Extremity Lymphedemas

MR lymphangiographic and Lymphoscintigraphic Bilateral Disease in Patients with Clinically Unilateral Cancer-related Lower Extremity Lymphedemas

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0007658
Enrollment
100
Registered
2022-08-26
Start date
2022-08-02
Completion date
Unknown
Last updated
2022-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Through a retrospective review of medical records, we analyze the results and medical records of tests performed on patients with unilateral lymphedema of the lower extremities at our hospital from January 2019 to March 2021.

Exclusion criteria

Exclusion criteria: Patients with bilateral lower extremity edema and upper extremity edema are excluded.

Design outcomes

Primary

MeasureTime frame
Results of Lymphoscintigraphy and MR lymphangiography of both leg—

Secondary

MeasureTime frame
Gender, age, BMI, smoking history, drinking history, hyperlipidemia, high blood pressure, chemotherapy history, radiation therapy history, edema stage of lower extremities, symptoms related to lower extremity edema, whether surgery, type of surgery—

Countries

Korea, Republic of

Contacts

Public ContactHyung Bae Kim

Asan Medical Center

hyungbae6051@naver.com+82-2-3010-1260

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026